Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Bioanalysis
|
September 6, 2022
Comparison of assay formats used for the detection of pre-existing anti-drug antibodies against monoclonal antibodies
Alexander Pöhler, Thomas Emrich, Gregor Jordan, et al.
The AAPS Journal
|
March 13, 2024
Biodistribution of Drug/ADA Complexes: The Impact of Immune Complex Formation on Antibody Distribution
Eugenia Opolka-Hoffmann, Martin R Edelmann, Michael B Otteneder, et al.
Pharmaceutical Research
|
June 30, 2019
Generation, Characterization, and Quantitative Bioanalysis of Drug/Anti-drug Antibody Immune Complexes to Facilitate Dedicated In Vivo Studies
Eugenia Hoffmann, Gregor Jordan, Matthias Lauer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 20, 2016
Immunogenicity, Inflammation, and Lipid Accumulation in Cynomolgus Monkeys Infused with a Lipidated Tetranectin-ApoA-I Fusion Protein
Franziska Regenass-Lechner, Roland F Staack, Jean-Luc Mary, et al.
Bioanalysis
|
August 9, 2025
Use of surrogate matrices in bioanalytical preclinical safety testing using immunoassay methods: a recommendation from the European Bioanalysis Forum
Richard Hughes, Gregor Jordan, Yvonne Katterle, et al.
Bioanalysis
|
June 15, 2023
Immunocapture LC-MS(/MS) assays for biotherapeutic and biomarker proteins: the European Bioanalysis Forum continuing discussions on scientific and regulatory challenges
Matthew Barfield, Michael Blackburn, Peter Blattmann, et al.
Bioanalysis
|
November 7, 2024
Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum community (Part 1: "The What")
Amanda Wilson, Mark Jean Gnoth, Nico van de Merbel, et al.
Bioanalysis
|
November 7, 2024
Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum community (Part 2: "The How")
Nico van de Merbel, Mark Jean Gnoth, Amanda Wilson, et al.
Bioanalysis
|
June 24, 2026
Fit-for-purpose application of LC-MS in protein bioanalysis, case studies shared within the European Bioanalysis Forum Hybrid MS team
Amanda Wilson, Richard Lucey, Emmanuel Njumbe Ediage, et al.
Nature Communications
|
June 26, 2020
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody
Martina Geiger, Kay-Gunnar Stubenrauch, Johannes Sam, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Bioanalysis
|
September 6, 2022
Comparison of assay formats used for the detection of pre-existing anti-drug antibodies against monoclonal antibodies
Alexander Pöhler, Thomas Emrich, Gregor Jordan, et al.
The AAPS Journal
|
March 13, 2024
Biodistribution of Drug/ADA Complexes: The Impact of Immune Complex Formation on Antibody Distribution
Eugenia Opolka-Hoffmann, Martin R Edelmann, Michael B Otteneder, et al.
Pharmaceutical Research
|
June 30, 2019
Generation, Characterization, and Quantitative Bioanalysis of Drug/Anti-drug Antibody Immune Complexes to Facilitate Dedicated In Vivo Studies
Eugenia Hoffmann, Gregor Jordan, Matthias Lauer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
January 20, 2016
Immunogenicity, Inflammation, and Lipid Accumulation in Cynomolgus Monkeys Infused with a Lipidated Tetranectin-ApoA-I Fusion Protein
Franziska Regenass-Lechner, Roland F Staack, Jean-Luc Mary, et al.
Bioanalysis
|
August 9, 2025
Use of surrogate matrices in bioanalytical preclinical safety testing using immunoassay methods: a recommendation from the European Bioanalysis Forum
Richard Hughes, Gregor Jordan, Yvonne Katterle, et al.
Bioanalysis
|
June 15, 2023
Immunocapture LC-MS(/MS) assays for biotherapeutic and biomarker proteins: the European Bioanalysis Forum continuing discussions on scientific and regulatory challenges
Matthew Barfield, Michael Blackburn, Peter Blattmann, et al.
Bioanalysis
|
November 7, 2024
Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum community (Part 1: "The What")
Amanda Wilson, Mark Jean Gnoth, Nico van de Merbel, et al.
Bioanalysis
|
November 7, 2024
Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum community (Part 2: "The How")
Nico van de Merbel, Mark Jean Gnoth, Amanda Wilson, et al.
Bioanalysis
|
June 24, 2026
Fit-for-purpose application of LC-MS in protein bioanalysis, case studies shared within the European Bioanalysis Forum Hybrid MS team
Amanda Wilson, Richard Lucey, Emmanuel Njumbe Ediage, et al.
Nature Communications
|
June 26, 2020
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody
Martina Geiger, Kay-Gunnar Stubenrauch, Johannes Sam, et al.
Page
of 4